india glp-1 India's Moment Could Reshape Sugar Market The GLP-1 Conversation We're Not

Founded in 2012 by a team of scientists from Harvard, Stanford, UC Berkeley, and Johns Hopkins, and led by Co-founder and CEO Colleen Cutcliffe, Ph.D., Pendulum translates cutting-edge microbiome research into clinically studied, targeted microbial solutions

doi: 10.1093/nutrit/nuae219

This boosts GLP-1 secretion in the gut, which reduces blood sugar, appetite and inflammation levels

doi:10.1093/ofid/ofae093

This has a broader population health benefit as greater access to these medicines will reduce the crippling strain obesity-related conditions have on NHS resources. In the UK, generic competition typically reduces prices paid by the NHS by as much as 80% to 90% after loss of exclusivity, according to the BGMA

No in-person visits Flexible appointment times Medication delivered to your home Ongoing communication with your provider Explore more insights and resources on our GLP-1 Blog